A China National Pharmaceutical Group unit said it’s received approval to start clinical trials in Hong Kong of two inactivated vaccines that target the omicron variant of coronavirus https://t.co/FwNNetUDVi— Bloomberg (@business) April 16, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


